Package 67877-868-33

{"route": ["ORAL"], "spl_id": "8dde15e5-8f0f-43bd-847f-08f5c015e4a1", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["205315", "205316"], "spl_set_id": ["cb966bcb-3af7-4dbe-b540-58d473b891e5"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 CAPSULE in 1 BOTTLE (67877-868-05)", "package_ndc": "67877-868-05", "marketing_start_date": "20240805"}, {"sample": false, "description": "1 BLISTER PACK in 1 CARTON (67877-868-33)  / 10 CAPSULE in 1 BLISTER PACK", "package_ndc": "67877-868-33", "marketing_start_date": "20240805"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (67877-868-60)", "package_ndc": "67877-868-60", "marketing_start_date": "20240805"}], "brand_name": "Topiramate", "product_id": "67877-868_8dde15e5-8f0f-43bd-847f-08f5c015e4a1", "dosage_form": "CAPSULE", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "67877-868", "generic_name": "Topiramate", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "15 mg/1"}], "application_number": "ANDA218482", "marketing_category": "ANDA", "marketing_start_date": "20240805", "listing_expiration_date": "20261231"}